Cabinet okays FDI of up to Rs 9,589 crore for 76.1% stake in Hyderabad-based Suven Pharma
Wednesday, 13 September 2023
The Cabinet Committee on Economic Affairs (CCEA) has approved a foreign direct investment (FDI) of up to Rs 9,589 crore by Cyprus-based Berhyanda Ltd in Hyderabad-based Suven Pharmaceuticals Ltd for a 76.1% interest. Advent Funds, operated by US-based private equity firm Advent International Corporation, own the Cyprus-based corporation.
|
||||
|
|
||||
You Might Like |
||||
